Injection Drug Users
Direct-acting Antivirals Could Dramatically Reduce Hepatitis C Transmission among IDUs
- Details
- Category: HCV Treatment
- Published on Thursday, 09 May 2013 00:00
- Written by Liz Highleyman
Widespread use of new direct-acting antiviral agents (DAAs) for hepatitis C could dramatically lower the rate of HCV transmission among people who inject drugs in 3 hard-hit cities, according to a math model described in the March 28, 2013, issue of Hepatology.
They assumed that interferon-free regimens would produce 90% sustained virological response (SVR) with 12 weeks of treatment and would be available by 2015 -- all "realistic scenarios" based on the latest research.
Naloxone Is Cost-effective Way to Prevent Heroin Overdose Deaths
- Details
- Category: Injection Drug Users
- Published on Thursday, 03 January 2013 00:00
- Written by Liz Highleyman
Distributing naloxone more widely to heroin users would reduce the number of deaths due to overdose and would be a cost-effective intervention, according to a mathematical model described in the January 1, 2013,Annals of Internal Medicine. Providing naloxone to prescription opiate users would prevent even more deaths.
ICAAC 2012: Hepatitis C Can Be Successfully Treated in Injection Drugs Users with or without HIV
- Details
- Category: HCV Treatment
- Published on Wednesday, 10 October 2012 00:00
- Written by Liz Highleyman
HIV negative and HIV positive chronic hepatitis patients in Vancouver with a history of injection drug use -- most of whom were on methadone maintenance -- achieved sustained response rates with interferon-based therapy similar to those of non-users, researchers reported at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012) last month in San Francisco. 
More Articles...
- High Rate of HCV Infection Shows Young Drug Injectors Need Better Prevention Interventions
- EACS: People on Methadone Maintenance Can Be Successfully Treated for Hepatitis C
- Injection Drug Users and Adherence to Hepatitis C Treatment
- 10 Million Injection Drug Users May Have Hepatitis B or C
- Advocates Urge Consideration of Hepatitis C Treatment for Active Injection Drug Users
- Active Injection Drug Users and Those on Opiate Substitution Treatment Can Have Good Hepatitis C Therapy Outcomes
- Active Injection Drug Use Does Not Impair Sustained Response to Hepatitis C Treatment in Adherent Patients
- Adherence to Hepatitis C Treatment among Recovering Heroin Users on Methadone Maintenance
Web Design and Development by